Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats

被引:29
作者
Sellings, L. H. L. [1 ]
McQuade, L. E. [1 ]
Clarke, P. B. S. [1 ]
机构
[1] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
dopamine; nucleus accumbens core; nucleus accumbens medial shell; olfactory tubercle; conditioned place preference; cis-flupenthixol;
D O I
10.1016/j.neuroscience.2006.04.040
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In general, psychostimulants are thought to exert rewarding and locomotor stimulating effects via increased dopamine transmission in the ventral striatum. However, little is known about the mechanisms underlying the effects of the stimulant drug methylphenidate. The present study examined the putative role of dopaminergic transmission in Lv. methylphenidate reward as measured by conditioned place preference. Rats were shown to exhibit conditioned place preference for Lv. methylphenidate (5 mg/kg, not 2 mg/kg). Administration of the dopamine receptor antagonist cis-flupenthixol (0.1-0.8 mg/kg i.p.), either during conditioning or on test day, dose-dependently attenuated the magnitude of the conditioned place preference. Finally, we examined the effects of bilateral 6-hydroxydopamine lesions of nucleus accumbens core, medial shell or anteromedial olfactory tubercle on the rewarding and locomotor stimulant effects of methylphenidate. Residual dopamine innervation, as assessed by radioligand binding to the dopamine transporter, revealed a significant association between core dopamine innervation and the locomotor stimulant effect of methylphenidate. However, neither core nor medial shell dopamine innervation was related to conditioned place preference magnitude. Instead, conditioned place preference magnitude was associated with dopamine innervation in the anteromedial olfactory tubercle. These results establish a role for dopaminergic transmission in both Lv. methylphenidate conditioned place preference and locomotor stimulation. As well, they suggest that different ventral striatal subregions mediate the rewarding (anteromedial olfactory tubercle) and locomotor stimulant (accumbens core) effects of methylphenidate. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1457 / 1468
页数:12
相关论文
共 45 条
[1]   Characteristics of methylphenidate misuse in a university student sample [J].
Barrett, SP ;
Darredeau, C ;
Bordy, LE ;
Pihl, RO .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (08) :457-461
[2]  
BERGMAN J, 1989, J PHARMACOL EXP THER, V251, P150
[3]  
Berridge CW, 1997, SYNAPSE, V27, P230, DOI 10.1002/(SICI)1098-2396(199711)27:3<230::AID-SYN8>3.0.CO
[4]  
2-E
[5]   Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats [J].
Boye, SM ;
Grant, RJ ;
Clarke, PBS .
NEUROPHARMACOLOGY, 2001, 40 (06) :792-805
[6]   Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain [J].
Campbell, A ;
Villavicencio, AT ;
Yeghiayan, SK ;
Balikian, R ;
Baldessarini, RJ .
BRAIN RESEARCH, 1997, 771 (01) :55-62
[7]   EFFECTS OF DOPAMINERGIC AND GLUTAMATERGIC RECEPTOR ANTAGONISTS ON THE ACQUISITION AND EXPRESSION OF COCAINE CONDITIONING PLACE PREFERENCE [J].
CERVO, L ;
SAMANIN, R .
BRAIN RESEARCH, 1995, 673 (02) :242-250
[8]   6-HYDROXYDOPAMINE LESIONS OF THE OLFACTORY TUBERCLE DO NOT ALTER (+)-AMPHETAMINE-CONDITIONED PLACE PREFERENCE [J].
CLARKE, PBS ;
WHITE, NM ;
FRANKLIN, KBJ .
BEHAVIOURAL BRAIN RESEARCH, 1990, 36 (1-2) :185-188
[9]   Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: Anterograde and retrograde tract-tracing studies in the rat [J].
Delfs, JM ;
Zhu, Y ;
Druhan, JP ;
Aston-Jones, GS .
BRAIN RESEARCH, 1998, 806 (02) :127-140
[10]   Dopamine and drug addiction: the nucleus accumbens shell connection [J].
Di Chiara, G ;
Bassareo, V ;
Fenu, S ;
De Luca, MA ;
Spina, L ;
Cadoni, C ;
Acquas, E ;
Carboni, E ;
Valentini, V ;
Lecca, D .
NEUROPHARMACOLOGY, 2004, 47 :227-241